Skin Dendritic Cells and Humoral Immunity

皮肤树突状细胞和体液免疫

基本信息

  • 批准号:
    9151875
  • 负责人:
  • 金额:
    $ 19.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-04-06 至 2020-03-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The importance of T cell based immunity in preventing skin infections is well studied and best exemplified by patients with genetic defects in the CD4+ Th17 pathway (e.g. hyper IgE syndrome). Patients with defects in the generation of antibody responses (e.g. X-linked agammaglobulinemia, hyper IgM syndrome) also suffer from recurrent skin bacterial pyogenic and viral infections. In addition, antibody responses to antigen found in the skin are pathogenic in numerous autoimmune blistering diseases and participate in atopic dermatitis and the atopic march. Despite the clear importance of humoral responses to skin health and disease, the mechanisms that generate antibody responses to cutaneous antigen are very poorly studied. Skin-resident dendritic cells (DC) are professional antigen presenting cells that acquire antigen in the skin. One DC subset, Langerhans cells (LC), form a dense DC network in the epidermis. They extend their dendrites to the upper epidermis and into the stratum corneum where they are able to acquire antigen. We have discovered that LC 1) drive the generation of CD4+ T follicular helper cells (Tfh) that provide T cell help for B cells ad 2) are sufficient to induce humoral response under steady-state conditions. Thus, a major unappreciated function of LC during homeostatic conditions is the generation of Tfh and the associated humoral response. The central hypothesis of this proposal is that LC have a unique role in the generation of antibody responses to cutaneous antigen. In addition to LC in the epidermis, there are 2 major subsets of DC in the dermis. In the setting of a skin infection all 3 DC subsets promote distinct Th subset differentiation. We hypothesize that this distinction occurs during steady-state conditions as well and that only LC have the capacity to differentiate Tfh. We hypothesized that in addition to expanding Tfh, LC also transport intact cutaneous antigen to B cells. Finally, we hypothesize that LC are required to promote antibody responses during pathogen infection and for the generation of antibodies against skin commensal microorganisms. Understanding which DC subset, conditions and pathways drive the formation of antibodies specific for cutaneous antigen is critical to understanding the mechanisms of resistance to skin pathogens and the etiology of antibody-mediated skin diseases. This work has the potential to provide novel therapeutic targets for the modulation of skin immune function.
 描述(由申请人提供):基于T细胞的免疫在预防皮肤感染中的重要性已得到充分研究,并且最好的例证是具有遗传缺陷的患者, CD4+ Th17通路(如高IgE综合征)。抗体应答产生缺陷的患者(例如X连锁无丙种球蛋白血症、高IgM综合征)也会遭受复发性皮肤细菌化脓性和病毒感染。此外,对皮肤中发现的抗原的抗体应答在许多自身免疫性起泡疾病中是致病性的,并且参与特应性皮炎和特应性进展。尽管体液应答对皮肤健康和疾病的重要性显而易见,但对产生针对皮肤抗原的抗体应答的机制的研究非常少。皮肤树突状细胞(DC)是一种专职的抗原提呈细胞,在皮肤中获得抗原。一个DC亚群,朗格汉斯细胞(LC),在表皮中形成致密的DC网络。它们将树突延伸到上表皮并进入角质层,在那里它们能够获得抗原。我们已经发现LC 1)驱动为B细胞提供T细胞帮助的CD 4 + T滤泡辅助细胞(Tfh)的产生,以及2)足以在稳态条件下诱导体液应答。因此,在稳态条件下LC的一个主要未被认识到的功能是产生Tfh和相关的体液反应。该建议的中心假设是LC在产生对皮肤抗原的抗体应答中具有独特的作用。除了表皮中的LC之外,真皮中还有2个主要的DC亚群。在皮肤感染的情况下,所有3个DC亚群促进不同的Th亚群分化。我们假设这种区别也发生在稳态条件下,只有LC有能力区分Tfh。我们假设除了扩增Tfh外,LC还将完整的皮肤抗原转运至B细胞。最后,我们假设,LC需要在病原体感染和产生针对皮肤微生物的抗体,以促进抗体反应。了解哪种DC亚群、条件和途径驱动皮肤抗原特异性抗体的形成对于理解对皮肤病原体的抗性机制和抗体介导的皮肤疾病的病因学至关重要。这项工作有可能为调节皮肤免疫功能提供新的治疗靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Daniel H Kaplan其他文献

Ontogeny and function of murine epidermal Langerhans cells
小鼠表皮朗格汉斯细胞的个体发育和功能
  • DOI:
    10.1038/ni.3815
  • 发表时间:
    2017-09-19
  • 期刊:
  • 影响因子:
    27.600
  • 作者:
    Daniel H Kaplan
  • 通讯作者:
    Daniel H Kaplan

Daniel H Kaplan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Daniel H Kaplan', 18)}}的其他基金

Assessing how ocular surface nerves, immune cells, and epithelial cells communicate to encourage neuro-immune homeostasis
评估眼表神经、免疫细胞和上皮细胞如何沟通以促进神经免疫稳态
  • 批准号:
    10595234
  • 财政年份:
    2022
  • 资助金额:
    $ 19.31万
  • 项目类别:
Assessing how ocular surface nerves, immune cells, and epithelial cells communicate to encourage neuro-immune homeostasis
评估眼表神经、免疫细胞和上皮细胞如何沟通以促进神经免疫稳态
  • 批准号:
    10707204
  • 财政年份:
    2022
  • 资助金额:
    $ 19.31万
  • 项目类别:
Immune Functions of Cutaneous Nociceptors
皮肤伤害感受器的免疫功能
  • 批准号:
    10534472
  • 财政年份:
    2017
  • 资助金额:
    $ 19.31万
  • 项目类别:
Immune Functions of Cutaneous Nociceptors
皮肤伤害感受器的免疫功能
  • 批准号:
    10671716
  • 财政年份:
    2017
  • 资助金额:
    $ 19.31万
  • 项目类别:
Skin Dendritic Cells and Humoral Immunity
皮肤树突状细胞和体液免疫
  • 批准号:
    9047238
  • 财政年份:
    2015
  • 资助金额:
    $ 19.31万
  • 项目类别:
Skin Dendritic Cells and Humoral Immunity
皮肤树突状细胞和体液免疫
  • 批准号:
    8891085
  • 财政年份:
    2015
  • 资助金额:
    $ 19.31万
  • 项目类别:
Regulated Activation of Latent-TGFb Determines Langerhans Cell Migration
潜在 TGFb 的调节激活决定朗格汉斯细胞迁移
  • 批准号:
    8508067
  • 财政年份:
    2011
  • 资助金额:
    $ 19.31万
  • 项目类别:
Regulated Activation of Latent-TGFb Determines Leukocyte Occupancy of the Epidermal Niche
潜在 TGFb 的调节激活决定白细胞对表皮生态位的占据
  • 批准号:
    9191681
  • 财政年份:
    2011
  • 资助金额:
    $ 19.31万
  • 项目类别:
Regulated Activation of Latent-TGFb Determines Langerhans Cell Migration
潜在 TGFb 的调节激活决定朗格汉斯细胞迁移
  • 批准号:
    9152349
  • 财政年份:
    2011
  • 资助金额:
    $ 19.31万
  • 项目类别:
Regulated Activation of Latent-TGFb Determines Langerhans Cell Migration
潜在 TGFb 的调节激活决定朗格汉斯细胞迁移
  • 批准号:
    8233827
  • 财政年份:
    2011
  • 资助金额:
    $ 19.31万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 19.31万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 19.31万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 19.31万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 19.31万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了